LifeStance Health Group (LFST) director Teresa DeLuca sells 20,441 shares
Rhea-AI Filing Summary
LifeStance Health Group, Inc. director Teresa DeLuca reported a sale of common stock. On 2026-08-13, she sold 20,441 shares of common stock at a reported price of $12.23 per share in a sale characterized as an open market or private transaction. Following this transaction, she directly holds 104,593 shares of LifeStance Health Group common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 20,441 shares
Net Sell
1 txn
Insider
DeLuca Teresa
Role
Director
Sold
20,441 shs ($250K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 20,441 | $12.23 | $250K |
Holdings After Transaction:
Common Stock — 104,593 shares (Direct)
Key Figures
Shares sold: 20,441 shares
Sale price per share: $12.23 per share
Shares held after transaction: 104,593 shares
3 metrics
Shares sold
20,441 shares
Common stock sold by director Teresa DeLuca on 2026-08-13
Sale price per share
$12.23 per share
Reported price for the 20,441 LFST shares sold
Shares held after transaction
104,593 shares
Direct holdings of LifeStance Health Group common stock after the sale
Key Terms
open market, private transaction, Rule 10b5-1 trading plan
3 terms
open market financial
"Sale in open market or private transaction"
An open market is a system where buying and selling of goods, services, or financial assets happen freely without restrictions or special controls. For investors, it means they can trade assets easily and quickly, which helps determine fair prices based on supply and demand. This environment encourages transparency and competition, making it easier to buy or sell with confidence.
private transaction financial
"Sale in open market or private transaction"
A private transaction is the sale or transfer of securities, assets, or ownership stakes carried out directly between a small number of parties rather than on a public exchange. For investors it matters because these deals are less visible and often less liquid than public trades, so pricing can be harder to verify, the investment can be harder to sell quickly, and buyers or sellers may gain strategic advantages not available in open markets — like negotiated terms similar to a private garage sale versus a crowded marketplace.
Rule 10b5-1 trading plan regulatory
"Rule 10b5-1 trading plan checkbox for this filing was not checked"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
FAQ
What insider transaction did LifeStance Health Group (LFST) report for Teresa DeLuca?
Teresa DeLuca, a director of LifeStance Health Group (LFST), reported selling 20,441 shares of common stock on 2026-08-13 in a sale described as an open market or private transaction.
Was Teresa DeLuca’s LFST stock sale reported under a Rule 10b5-1 trading plan?
The Rule 10b5-1 trading plan checkbox for this filing was not checked. The disclosure does not indicate that the reported 20,441-share sale was executed pursuant to an affirmed Rule 10b5-1 trading plan.
What type of transaction code was used for Teresa DeLuca’s LFST stock sale?
The transaction used code S, described as a “Sale in open market or private transaction.” It involved 20,441 shares of LifeStance Health Group common stock at $12.23 per share on 2026-08-13.
AI-generated analysis. How Rhea-AI works. Not financial advice.
